BiologIC is hugely excited about Advanced Therapies (ATs) and we see a new era of medicine enabled by these therapies.
One opportunity in this new era is the model of delivery of therapies to patients. BiologIC recently authored a thought leadership piece in OnDrugDelivery on how the current slow-moving blockbuster treatment model will make way for a fast-moving, patient-focused era of personalised medicine – creating new opportunities for flexible, decentralised AT manufacture closer to the patient.
Read the full text here: https://www.ondrugdelivery.com/a-flexible-modular-platform-to-disrupt-the-blockbuster-manufacturing-model/
We’d love to hear your thoughts and opinions on this, get in touch on This email address is being protected from spambots. You need JavaScript enabled to view it.